244 results
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
3:28pm
pending the Panel’s decision. There can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the Panel … , there can be no assurance that the Company will be successful in developing the Compliance Plan, that the Compliance Plan will be accepted by Nasdaq, or even
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
9:17am
, it would remain listed pending the Panel’s decision. There can be no assurance that, if the Company does appeal the delisting determination … Requirement. However, there can be no assurance that the Company will be successful in developing the Compliance Plan, that the Compliance Plan
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
) The Company acknowledges and agrees that (A) there can be no assurance that the Manager will be successful in selling the Shares, (B) the Manager will incur … of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general
424B5
zq0qdkauox g6
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
jlcgdbsmr5
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
47lsy58vjielvdsi9a01
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
a62e08wpvu823if
13 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm